Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience

Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience

Abstract Nivolumab is an effective and safe treatment in HCC.

Bibliographic Details
Main Authors: Ouissam Al jarroudi, Hamed Chaabouni, Ayhan Ulusakarya, Wathek Almohamad, Yusuf Gumus, Emma Goldschmidt, Said Afqir, Jean‐francois Morère
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Clinical Case Reports
Subjects:
clinical outcomes
hepatocellular carcinoma
nivolumab
survival
Online Access:https://doi.org/10.1002/ccr3.3970
Description
Summary:Abstract Nivolumab is an effective and safe treatment in HCC.
ISSN:2050-0904

Similar Items